Trial Outcomes & Findings for The Drinking Dashboard Study (NCT NCT05630625)
NCT ID: NCT05630625
Last Updated: 2026-08-07
Results Overview
% of eligible screening participants who (yes/no) complete the baseline assessment (no specific tool)
COMPLETED
NA
169 participants
Baseline
2026-08-07
Participant Flow
Participant milestones
| Measure |
Drinking Dashboard
Day-level feedback on alcohol use and consequences
Drinking Dashboard: Day-level feedback on alcohol use and consequences
|
Assessment Only
Daily assessment control group
|
|---|---|---|
|
Overall Study
STARTED
|
87
|
82
|
|
Overall Study
COMPLETED
|
74
|
82
|
|
Overall Study
NOT COMPLETED
|
13
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Data for participants included in primary analyses
Baseline characteristics by cohort
| Measure |
Drinking Dashboard
n=74 Participants
Day-level feedback on alcohol use and consequences
|
Assessment Only
n=82 Participants
Daily assessment control group
|
Total
n=156 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
22.11 years
STANDARD_DEVIATION 2.79 • n=20 Participants • Data for participants included in primary analyses
|
22.07 years
STANDARD_DEVIATION 2.68 • n=20 Participants • Data for participants included in primary analyses
|
22.09 years
STANDARD_DEVIATION 2.72 • n=40 Participants • Data for participants included in primary analyses
|
|
Sex: Female, Male
Female
|
42 Participants
n=20 Participants
|
49 Participants
n=20 Participants
|
91 Participants
n=40 Participants
|
|
Sex: Female, Male
Male
|
32 Participants
n=20 Participants
|
33 Participants
n=20 Participants
|
65 Participants
n=40 Participants
|
|
Race/Ethnicity, Customized
Asian only
|
3 Participants
n=20 Participants
|
6 Participants
n=20 Participants
|
9 Participants
n=40 Participants
|
|
Race/Ethnicity, Customized
Black only
|
2 Participants
n=20 Participants
|
3 Participants
n=20 Participants
|
5 Participants
n=40 Participants
|
|
Race/Ethnicity, Customized
Hispanic or Latine only
|
9 Participants
n=20 Participants
|
9 Participants
n=20 Participants
|
18 Participants
n=40 Participants
|
|
Race/Ethnicity, Customized
White only
|
48 Participants
n=20 Participants
|
49 Participants
n=20 Participants
|
97 Participants
n=40 Participants
|
|
Race/Ethnicity, Customized
Other race
|
1 Participants
n=20 Participants
|
0 Participants
n=20 Participants
|
1 Participants
n=40 Participants
|
|
Race/Ethnicity, Customized
Multiracial or Multiethnic
|
11 Participants
n=20 Participants
|
15 Participants
n=20 Participants
|
26 Participants
n=40 Participants
|
|
En bloc blackout
|
55 Participants
n=20 Participants
|
56 Participants
n=20 Participants
|
111 Participants
n=40 Participants
|
PRIMARY outcome
Timeframe: Baseline% of eligible screening participants who (yes/no) complete the baseline assessment (no specific tool)
Outcome measures
| Measure |
Total Screened
n=487 Participants
Total participants that complete initial screening.
|
Assessment Only
Daily assessment control group
|
|---|---|---|
|
Recruitment
|
248 Participants
|
—
|
PRIMARY outcome
Timeframe: 3-month follow-up% of randomized participants who (yes/no) complete 3-month follow-up assessment (no specific tool)
Outcome measures
| Measure |
Total Screened
n=87 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Retention
|
73 Participants
|
72 Participants
|
PRIMARY outcome
Timeframe: 1 month follow-upMeasured using the 8-item Client Satisfaction Questionnaire. Scored from 1 to 4, with higher scores indicating greater satisfaction with treatment.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
Daily assessment control group
|
|---|---|---|
|
Acceptability
|
2.91 units on a scale
Standard Deviation 0.40
|
—
|
PRIMARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: Numbers differ due to attrition.
Measured using the Daily Drinking Questionnaire, which asks participants to indicate how many standard drinks they consumed on each day of a typical week in the past month.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Frequency of High-intensity Drinking
Baseline
|
3.36 drinks per day
Standard Deviation 3.52
|
2.91 drinks per day
Standard Deviation 3.25
|
|
Frequency of High-intensity Drinking
Post-treatment
|
2.68 drinks per day
Standard Deviation 3.29
|
2.18 drinks per day
Standard Deviation 3.01
|
|
Frequency of High-intensity Drinking
3 months
|
1.47 drinks per day
Standard Deviation 2.02
|
1.88 drinks per day
Standard Deviation 2.66
|
PRIMARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: Numbers differ due to attrition.
Measured using the Daily Drinking Questionnaire, which asks participants to indicate the maximum number of drinks consumed on one occasion in the past month. Estimated using Widmark's formula (1932).
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Change in Peak BAC From Baseline
Baseline
|
.20 percentage of alcohol/100 ml of blood
Standard Deviation .09
|
.19 percentage of alcohol/100 ml of blood
Standard Deviation .10
|
|
Change in Peak BAC From Baseline
Post-treatment
|
0.18 percentage of alcohol/100 ml of blood
Standard Deviation 0.10
|
0.17 percentage of alcohol/100 ml of blood
Standard Deviation 0.12
|
|
Change in Peak BAC From Baseline
3 Months
|
0.14 percentage of alcohol/100 ml of blood
Standard Deviation 0.94
|
0.14 percentage of alcohol/100 ml of blood
Standard Deviation 0.11
|
PRIMARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: Number is different due to attrition.
Measured using the 8-item Alcohol-Induced Blackout Measure-2 (ABOM-2). Participants indicate how often they have experienced 8 different blackout experiences (e.g., having fuzzy memories of drinking events, being unable to remember hours at a time) in the past month on a scale from 0 (never) to 4 (4 or more times). Item scores are summed to create a total score that ranges from 0 to 32, with higher scores indicating more frequent blackout experiences.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Frequency of Blackouts
Baseline
|
12.82 units on a scale
Standard Deviation 7.78
|
12.48 units on a scale
Standard Deviation 7.77
|
|
Frequency of Blackouts
Post-treatment
|
8.99 units on a scale
Standard Deviation 7.51
|
7.46 units on a scale
Standard Deviation 7.06
|
|
Frequency of Blackouts
3 Months
|
6.65 units on a scale
Standard Deviation 6.56
|
5.66 units on a scale
Standard Deviation 7.07
|
PRIMARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: Number is different due to attrition.
Measured using the 24-item Brief Young Adult Alcohol Consequences Questionnaire (BYAACQ). Participants indicate (0=no, 1=yes) if they experienced 24 consequences as a result of drinking in the past month. Items are summed to create a total score, with higher scores indicating a greater number of consequences in the past month.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Alcohol-related Consequences
3 Months
|
6.03 score on a scale
Standard Deviation 5.06
|
5.75 score on a scale
Standard Deviation 5.48
|
|
Alcohol-related Consequences
Baseline
|
11.39 score on a scale
Standard Deviation 4.77
|
11.20 score on a scale
Standard Deviation 4.86
|
|
Alcohol-related Consequences
Post-treatment
|
8.59 score on a scale
Standard Deviation 4.80
|
7.42 score on a scale
Standard Deviation 4.79
|
SECONDARY outcome
Timeframe: Difference in likelihood baseline vs 3 monthsPopulation: participants
% of people indicating they (a) were coerced into sexual activity or (b) coerced someone else into sexual activity in the past 3 months
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Sexual Coercion
Baseline
|
16 Participants
|
16 Participants
|
|
Sexual Coercion
Post-treatment
|
11 Participants
|
8 Participants
|
|
Sexual Coercion
3-month follow-up
|
7 Participants
|
5 Participants
|
SECONDARY outcome
Timeframe: Difference in likelihood baseline vs 3 monthsPopulation: participants
% of people indicating they visited the emergency department in the past 3 months
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Emergency Department Visits
3-month follow-up
|
2 Participants
|
1 Participants
|
|
Emergency Department Visits
Baseline
|
3 Participants
|
7 Participants
|
|
Emergency Department Visits
Post-treatment
|
0 Participants
|
2 Participants
|
SECONDARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: participants
How likely is it that you will lose memory of drinking events as a result of alcohol use in the next 30 days? Scored on 0-100 scale, with higher scores indicating more susceptibility.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=81 Participants
Daily assessment control group
|
|---|---|---|
|
Blackout Susceptibility
Baseline
|
51.32 score on a scale
Standard Deviation 29.07
|
49.77 score on a scale
Standard Deviation 51.32
|
|
Blackout Susceptibility
Post-treatment
|
40.85 score on a scale
Standard Deviation 30.39
|
34.25 score on a scale
Standard Deviation 29.66
|
|
Blackout Susceptibility
3-month follow-up
|
32.86 score on a scale
Standard Deviation 31.69
|
24.34 score on a scale
Standard Deviation 24.53
|
SECONDARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: participants
Participants responded to 6 items indicating the extent to which they believed that blackouts would be (1) enjoyable, (2) good, (3) beneficial, (4) wise, (5) pleasant, and (6) safe. Responses were strongly disagree =1, disagree = 2, neutral = 3, agree = 4, strongly agree = 5. Scores from each of the six items were averaged, with higher scores indicating more positive expectancies for blackout.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Blackout Expectancies (Scale Developed by Investigators for This Study)
Baseline
|
3.45 score on a scale
Standard Deviation 4.14
|
2.91 score on a scale
Standard Deviation 3.19
|
|
Blackout Expectancies (Scale Developed by Investigators for This Study)
Post-treatment
|
3.42 score on a scale
Standard Deviation 4.01
|
2.64 score on a scale
Standard Deviation 3.30
|
|
Blackout Expectancies (Scale Developed by Investigators for This Study)
3-month follow-up
|
2.89 score on a scale
Standard Deviation 3.38
|
3.71 score on a scale
Standard Deviation 4.02
|
SECONDARY outcome
Timeframe: Change from baseline to post-treatment (five weeks later)Population: participants
Measured using the Alcohol and Drug Consequences Questionnaire scale. Participants indicated the extent to which they agreed with 16 statements regarding the benefits of decreased alcohol use (e.g., I would feel better physically). Responses range 0 (not important / wouldn't happen) to 4 (extremely important). Responses are summed, with higher scores indicating greater perceived benefits of decreasing alcohol use.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=79 Participants
Daily assessment control group
|
|---|---|---|
|
Costs/Benefits of Drinking
Baseline
|
13.11 score on a scale
Standard Deviation 1.52
|
13.42 score on a scale
Standard Deviation 1.51
|
|
Costs/Benefits of Drinking
Post-treatment
|
23.61 score on a scale
Standard Deviation 12.04
|
24.11 score on a scale
Standard Deviation 13.44
|
SECONDARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: participants
% confidence that participants could avoid a blackout, if they wanted to do so
Outcome measures
| Measure |
Total Screened
n=73 Participants
Total participants that complete initial screening.
|
Assessment Only
n=81 Participants
Daily assessment control group
|
|---|---|---|
|
Blackout Self-efficacy
Post-treatment
|
82.73 score on a scale
Standard Deviation 20.58
|
84.91 score on a scale
Standard Deviation 25.16
|
|
Blackout Self-efficacy
3-month follow-up
|
86.08 score on a scale
Standard Deviation 21.64
|
84.11 score on a scale
Standard Deviation 26.71
|
|
Blackout Self-efficacy
Baseline
|
77.19 score on a scale
Standard Deviation 25.88
|
77.28 score on a scale
Standard Deviation 27.73
|
SECONDARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: participants
Measured using the Insomnia Severity Index. Participants rate the extent to which they have struggled with sleep in the past two weeks (e.g., difficulty falling asleep, difficulty staying asleep, worry/distress about sleep). Responses range from 0 (e.g., none) to 4 (e.g., very severe). Items are summed and range 0-28, with higher scores indicating more severe insomnia.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=82 Participants
Daily assessment control group
|
|---|---|---|
|
Sleep Disturbance
Baseline
|
8.74 score on a scale
Standard Deviation 4.56
|
11.04 score on a scale
Standard Deviation 5.90
|
|
Sleep Disturbance
Post-treatment
|
8.59 score on a scale
Standard Deviation 4.77
|
8.91 score on a scale
Standard Deviation 5.42
|
|
Sleep Disturbance
3-month follow-up
|
7.11 score on a scale
Standard Deviation 4.27
|
8.93 score on a scale
Standard Deviation 5.86
|
SECONDARY outcome
Timeframe: Change from baseline to follow-up (1 and 3 months)Population: participants
Measured using the Positive and Negative Affect Schedule. Scores range 1 (very slightly or not at all) to 5 (extremely), with higher scores indicating more negative mood.
Outcome measures
| Measure |
Total Screened
n=74 Participants
Total participants that complete initial screening.
|
Assessment Only
n=81 Participants
Daily assessment control group
|
|---|---|---|
|
Mood
Baseline
|
23.70 score on a scale
Standard Deviation 8.26
|
22.58 score on a scale
Standard Deviation 7.50
|
|
Mood
3-month follow-up
|
22.61 score on a scale
Standard Deviation 8.49
|
22.18 score on a scale
Standard Deviation 6.84
|
|
Mood
Post-treatment
|
22.73 score on a scale
Standard Deviation 7.98
|
22.65 score on a scale
Standard Deviation 7.12
|
Adverse Events
Drinking Dashboard
Assessment Only
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place